Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
904
Total Claims
$1.3M
Drug Cost
174
Beneficiaries
$7,242
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+55%
Opioid rate vs peers
9.7% vs 6.3% avg
-47%
Cost per patient vs peers
$7,242 vs $14K avg
Opioid Prescribing
9.7%
Opioid Rate
88
Opioid Claims
$1,426
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 775 claims · $55K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Lenvatinib Mesylate | 11 | $291K |
| Telotristat Etiprate | 20 | $191K |
| Lipase/Protease/Amylase | 21 | $38K |
| Apixaban | 28 | $35K |
| Everolimus | 12 | $32K |
| Dronabinol | 19 | $2,429 |
| Letrozole | 52 | $1,228 |
| Ondansetron | 62 | $1,177 |
| Oxycodone Hcl | 68 | $1,029 |
| Diphenoxylate Hcl/Atropine | 29 | $976 |
| Lidocaine/Prilocaine | 49 | $896 |
| Cyproheptadine Hcl | 22 | $744 |
| Duloxetine Hcl | 33 | $394 |
| Dexamethasone | 13 | $385 |
| Tamoxifen Citrate | 19 | $328 |
Prescribing Profile
Patient Profile
72
Avg Age
51%
Female
3.04
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About